MYCN and neuroblastoma: In neuroblastoma, the PI3/Akt/mTOR pathway has been found to affect multiple pathways/proteins to enhance the neuroblastoma phenotype, such as stabilizing MYCN, which in turn facilitates processes associated with malignancy like proliferation, angiogenesis, and metabolic reprogramming (11, 12).